Manufacturers looking to put into action these procedures must give strong validation data to exhibit their equivalence to pharmacopoeial procedures. As these new technologies arise, the WHO emphasizes the importance of a radical danger evaluation and validation procedure. As the earth current market leader while in the pharmaceutical sec